StockData
Trupanion, Inc. logo

Trupanion, Inc. (TRUP) company profile

TRUPNasdaqHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3051% above fair value
$34.48+0.18 (+0.52%)

Close on Nov 13, 2026Market cap $1.51BP/E 56.5Yield –

About Trupanion

Hospital & Medical Service Plans, SIC 6324

Trupanion, Inc. provides medical insurance plans for cats and dogs. The company operates through two main business segments: subscription business and other business. In its subscription segment, Trupanion offers direct-to-consumer medical insurance policies under the Trupanion brand, as well as products under brand names like Furkin and PHI Direct, alongside co-branded offerings marketed by third parties. Its other business segment provides commercial underwriting services for third-party insurance partners, employer-sponsored initiatives, and the U.S. Department of Veterans Affairs. Trupanion primarily serves pet owners, veterinary hospitals, and business-to-business corporate clients seeking pet health coverage solutions.

The company is headquartered in Seattle, Washington. Trupanion operates across the United States, Canada, and select countries in Continental Europe, with additional office locations in the United Kingdom, Germany, and Czechia. It employs over 1,100 people across North America and Europe, supported by independent territory partners, while also contracting with service personnel in India and the Philippines.

Summary of the business section of Trupanion's latest annual report, written by StockData.

Company profile

Company

Legal name
Trupanion, Inc.
Founded
2000
Headquarters
Seattle, WA
Address
6100 4th Avenue South, Suite 400 98108
Phone
(888) 733-2685
Employees
1,121, Dec 31, 2025
Industry
Hospital & Medical Service Plans
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Ernst & Young LLP, Seattle, Washington

Stock & identifiers

Ticker
TRUP
Exchange
Nasdaq
IPO date
Jul 18, 2014
Shares outstanding
44M, Jul 29, 2026
Public float
$1.32B, Jun 30, 2025
Filer category
Large accelerated filer
SEC CIK
1371285
CUSIP
898202106
ISIN
US8982021060
FIGI
BBG002BC7WC5
Share class FIGI
BBG002BC7WF2
LEI
549300J86GFKIDGMQP18
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Margaret ToothCEO, Director182,952
John R. GallagherChief Operating Officer32,880
Brenna McGibneyChief Administration Officer14,274
Simon WheelerEVP, Trupanion International25,327
Asher BearmanChief Legal Officer74,013
Steve WeinrauchEVP, North Am & Vet Strategy81,481
Fawwad QureshiChief Financial Officer4,230
Katherine SeawellChief Marketing Officer–
Emily DreyerChief Revenue Officer35,627
Christopher J. KearnsChief Legal Officer12,794
Jason WasdinGeneral Manager4,478
Melissa Joy HewittGeneral Manager9,477
Kalpesh RavalGeneral Manager3,513
Travis WorraGeneral Manager3,987
Murray B. LowDirector302,531
Howard E. RubinDirector203,288
Darryl RawlingsDirector1,460,491
Bradley S. PowellDirector3,546
Paulette R. DodsonDirector8,526
Elizabeth McLaughlinDirector10,635
Max BrodenDirector8,571
Jacqueline L. DavidsonDirector16,564

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Darryl Rawlings
$0$0$2.14M$31$167
FY2025
Margi Tooth
$4.11M$2.58M$2.14M$31$167
FY2024
Darryl Rawlings
$1.70M$2.98M$1.40M$131$189
FY2024
Margi Tooth
$4.41M$6.56M$1.40M$131$189
FY2023$321.90K-$231.46K$705.74K$83$176
FY2022$1.66M-$4.04M$3.47M$129$106

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsIncentive payTotalvs. prior year
Margi Tooth
Chief Executive Officer, President
$641.67K$2.43M$1.04M$4.11M-7%
Fawwad Qureshi
Chief Financial Officer
$436.67K$2.04M$641.90K$3.12M+220%
John Gallagher
Chief Operating Officer
$375.00K$1.30M$413.44K$2.08M+33%
Emily Dreyer
Chief Revenue Officer
$317.50K$1.01M$280.04K$1.61M–
Dr. Steve Weinrauch
Chief Product & Veterinary Officer
$327.50K$1.14M$288.86K$1.76M+105%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Jul 18, 2014
Offer price
$10.00
Securities offered
7,125,000
Gross proceeds
$71.25M
Exchange
NYSE
First trading day
Jul 18, 2014
First-day close
$11.40+14.0%
Lock-up ends (est.)
Jan 14, 2015

“PER SHARE TOTAL Public Offering Price $ 10.00 $ 71,250,000 Underwriting Discounts and Commissions (1) $ 0.70 $ 4,987,500 Proceeds to Trupanion, Inc.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we employed 1,121 people across the U.S., Canada and Europe, with women representing 63% of leadership positions.”

Corporate history

Events identified from SEC filings

DateEventDetails
Aug 14, 2018Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jun 16, 2016ListingRegistration of securities on an exchange (Form 8-A)
Jun 16, 2016DelistingNotice of delisting from exchange (Form 25)
Jun 6, 2016Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jul 18, 2014IPOInitial public offering priced (424B4 prospectus)
Jul 11, 2014ListingRegistration of securities on an exchange (Form 8-A)
Nov 9, 2011Name changeName changed from VETINSURANCE INTERNATIONAL INC to TRUPANION INC.

See a number that looks wrong?